SOLO BRANDS INC (SBDS)
OTCConsumer DiscretionarySpecialty RetailSnapshot 2026-10-29
$2.45-2.00%
Close 2026-10-30 · 1-day change
OTCConsumer DiscretionarySpecialty RetailSnapshot 2026-10-29
Research Workspace
Put SBDS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Resolve NYSE delisting notice: Direct metric needs a verified mapping.
View ThesisRevenue is contracting — down about 27% over the past year.
View GrowthManagement screens weak on capital allocation, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 87% in its worst 12-month stretch.
View RiskSBDS would be a bet on a recovery, but its latest reported revenue fell year over year. Q2 FY2026 revenue declined 4.1%, and the company was unprofitable over the past year. The desk has no valuation multiples or priced-in expectations for SBDS. Frequent disruptive corporate change and a high-risk rating weigh on the recovery case. The primary pillar is resolving an NYSE delisting notice, with its metric mapping unverified. The thesis is on watch; this read is provisional.
Trailing returns as of 2026-10-30. SBDS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare SBDS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| SBDS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Other Specialty Retail — fair value, gap to price, and forward P/E.
Compare the value case
Put SBDS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Improve profitability and cash flow
Adjusted EBITDA surge indicates improved profitability and cash flow.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Improve cash flow from operations
Distribution cut and capex investment may improve cash flow.
